Advertisement

C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!

Pharma Press Releases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

Aquestive Therapeutics Receives FDA Tentative Approval for Libervant™ (diazepam) Buccal Film

Wednesday, August 31, 2022

Aquestive Therapeutics Inc a pharmaceutical company advancing medicines to solve patients problems with current standards of care and provide transformative products to improve their lives announced today that the US Food Drug Administration FDA has...

XenpozymeTM (olipudase alfa-rpcp) approved by FDA as first disease-specific treatment for ASMD (non-CNS manifestations)

Wednesday, August 31, 2022

The US Food and Drug Administration FDA has approved XenpozymeTM olipudase alfarpcp for the treatment of noncentral nervous system nonCNS manifestations of acid sphingomyelinase deficiency ASMD in adult and pediatric patients Xenpozyme is the first t...

IDEAYA Announces Achievement of First Milestone in Ongoing Collaboration with GSK for Potential First-in-Class Pol Theta Helicase Inhibitor Development Candidate

Monday, August 29, 2022

IDEAYA Biosciences Inc a synthetic lethality focused precision medicine oncology company committed to the discovery and development of targeted therapeutics announced that it has achieved a preclinical development milestone in connection with ongoing...

Mydecine Innovations Group Announces Common Share Subscription Agreement

Monday, August 29, 2022

Mydecine Innovations Group Inc a biotechnology company engineering the next wave of innovative medications and treatment protocols to directly address mental health with a particular emphasis on addiction and PTSD today announced that it has entered...

ASC Announces the Expansion of its cGMP Manufacturing Facility to Support Cell and Gene Therapy

Monday, August 29, 2022

Applied StemCell Inc ASC a leading cell and gene therapy CROCDMO focused on supporting the research community and biotechnology industry for their needs in developing and manufacturing cell and gene products today announced the expansion of its Curre...

Tagrisso approved in Japan for the adjuvant treatment of patients with early-stage EGFR-mutated lung cancer

Thursday, August 25, 2022

AstraZenecas Tagrisso osimertinib has been approved in Japan for the adjuvant treatment of patients with epidermal growth factor receptormutated EGFRm nonsmall cell lung cancer NSCLC after surgery This approval by the Japanese Ministry of Health Labo...

ASLAN Pharmaceuticals Signs License Agreement With Belle.ai to Use bellestudy Image Capture Software in Atopic Dermatitis Clinical Trials

Thursday, August 25, 2022

BelleTorus Corporation and ASLAN Pharmaceuticals today announced that ASLAN has licensed belleStudy digital image capture software in support of ASLANs clinical trials for atopic dermatitis AD across several global sites ASLAN will make the image cap...

Arbor Biotechnologies Enters into Agreement with Acuitas Therapeutics for Lipid Nanoparticle Delivery System for Use in Rare Liver Diseases

Thursday, August 25, 2022

Arbor Biotechnologies a biotechnology company discovering and developing the next generation of genetic medicines today announced that it has entered into an agreement with Acuitas Therapeutics a leader in the development of lipid nanoparticles LNP A...

BioCardia Enters Agreement with BlueRock Therapeutics to Provide Enabling Catheter Biotherapeutic Delivery Product Candidates for BlueRock’s Cell Therapy to Treat Heart Failure

Wednesday, August 24, 2022

BioCardia Inc today announced that it has entered into an agreement with BlueRock Therapeutics LP for the delivery of BlueRocks cell therapy product candidates for the treatment of heart failure utilizing BioCardias minimally invasive biotherapeutic...

SciSparc Ltd. Announces Additional Positive Results for the Cocaine Addiction Treatment of its Psychedelic-based Pharma Collaboration with Clearmind Medicine Inc.

Wednesday, August 24, 2022

SciSparc Ltd a specialty clinicalstage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system the Company or SciSparc today announced additional positive preclinical results of its Psychedelic...